About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs


  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank


« Conference & CLE Calendar | Main | USPTO Releases Memorandum on Subject Matter Eligibility »

July 17, 2016


Dear Patent Docs:
Thank you for your regular enlightenment.
In the case of "United Therapeutics Corp. et al. v. Actavis Laboratories FL, Inc.", is it possible that the link to the complaint is not correct? The words "Actavis" and "Orenitram" cannot be found, therein.

Hi Charles - sorry about that. You were right, the wrong complaint was inadvertently linked to the post. We have now corrected that. Thanks for letting us know!

Thanks for the reactivity also!

The comments to this entry are closed.

February 2024

Sun Mon Tue Wed Thu Fri Sat
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29